Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bon Natural Life ( (BON) ) has provided an announcement.
Bon Natural Life Limited, a Nasdaq-listed supplier of natural active ingredients for health and personal care products, operates globally with a portfolio spanning plant-based extracts, functional food ingredients and personal care actives. The company relies on advanced extraction and biosynthesis technologies, including an AI-driven bio-manufacturing platform, to support large-scale, high-quality production for customers in major markets worldwide.
On January 22, 2026, Bon’s subsidiary Xi’an App-Chem Bio-Tech Co., Ltd. signed a three-year framework cooperation agreement with Shaanxi Chang’an Pilot Life Science Industry Innovation Center to build an integrated innovation chain from basic research to industrial application. Under this collaboration, formally highlighted on February 17, 2026, the parties inaugurated the BON & Pilot Joint Laboratory on December 18, 2025 to develop AI-enhanced biomanufactured natural ingredients, and plan an engineering center plus broader R&D, market and capital partnerships that could bolster Bon’s efficiency, supply reliability and competitive position in bio-manufactured ingredients.
The most recent analyst rating on (BON) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Bon Natural Life stock, see the BON Stock Forecast page.
Spark’s Take on BON Stock
According to Spark, TipRanks’ AI Analyst, BON is a Neutral.
The score is primarily constrained by weak financial performance—especially persistent negative free cash flow and deteriorating profitability. Technical indicators are mixed/neutral with mild bearish momentum, and valuation is challenging due to losses (negative P/E) with no dividend support.
To see Spark’s full report on BON stock, click here.
More about Bon Natural Life
Bon Natural Life Limited, listed on Nasdaq as BON, is a Cayman Islands-based bio-ingredient provider focused on the natural health and personal care industries. Founded in 2006, the company develops, manufactures and commercializes plant-derived extracts, functional food ingredients and personal care actives, serving customers across China, North America, the European Union, Japan, South Korea and other international markets. It leverages capabilities in natural ingredient extraction, separation and biosynthesis through a proprietary AI-enabled biomanufacturing R&D platform aimed at scalable, data-driven production.
Average Trading Volume: 33,302
Technical Sentiment Signal: Sell
Current Market Cap: $13.33M
See more data about BON stock on TipRanks’ Stock Analysis page.